T / Tn Antigen Antibody Duo (T , Tn)

Key features and details

  • 产品描述: The first step in O-linked oligosaccharide synthesis is adding a N-acetylgalactosamine to serine or threonine resulting in the formation of the Tn antigen and Tn antigen can be proceed along different pathways through different glycosylation processes. The galactose can be added on Tn antigen by a β1,3-galactosyltransferase results in the formation of the Thomsen-Friedenreich antigen (Galβ1,3GalNAcα-O-Ser/Thr) also known as Thomsen–Friedenreich (T or TF) antigen or CD176. The patents with Tn syndrome are β1,3-galactosyltransferase deficiention resulting in the expression of Tn antigen on their hematopoietic cells. Both antigens have been shown previously to correlate with various cancer types. The abnormal protein glycosylation might associated with human cancer and the identification of protein glycoforms might be cancer biomarkers and therapeutic targets. Recently study find that the O-link glycan changes in some of the surface protein, for Ex, MUC1 and CD43, might also undergoing EMT and metastases activity. arigo provides a T/Tn antigen antibody Duos, ARG30016, including antibodies reacting T antigen and Tn antigen for users to study the potentially glycol-structure and glycan changes of the target protein and it might be useful to findout the biomarker and therapeutic agent.
  • 靶点名称: T / Tn Antigen
  • 別名: T / Tn Antigen antibody; Tn antigen antibody; Thomsen-Friedenreich Antigen antibody
  • Brand:
CAT.NO. : ARG30016
US$ Please choose
US$ Please choose
Size:
Trail, Bulk size or Custom requests Please contact us
*产品价格可能会有所调整,请以品牌方官网实时更新的价格为准,以确保准确性。
Product Details
内含物
货号内含物名称宿主克隆性反应应用包装
ARG62636anti-Thomsen-Friedenreich Antigen antibody [A78-G/A7]Mouse mAbHu, RatICC/IF, IHC-P250 μl
ARG53970anti-Tn antigen antibody [Tn 218]Mouse mAbHuICC/IF, IHC250 μl
概述
产品描述The first step in O-linked oligosaccharide synthesis is adding a N-acetylgalactosamine to serine or threonine resulting in the formation of the Tn antigen and Tn antigen can be proceed along different pathways through different glycosylation processes. The galactose can be added on Tn antigen by a β1,3-galactosyltransferase results in the formation of the Thomsen-Friedenreich antigen (Galβ1,3GalNAcα-O-Ser/Thr) also known as Thomsen–Friedenreich (T or TF) antigen or CD176. The patents with Tn syndrome are β1,3-galactosyltransferase deficiention resulting in the expression of Tn antigen on their hematopoietic cells. Both antigens have been shown previously to correlate with various cancer types. The abnormal protein glycosylation might associated with human cancer and the identification of protein glycoforms might be cancer biomarkers and therapeutic targets. Recently study find that the O-link glycan changes in some of the surface protein, for Ex, MUC1 and CD43, might also undergoing EMT and metastases activity. arigo provides a T/Tn antigen antibody Duos, ARG30016, including antibodies reacting T antigen and Tn antigen for users to study the potentially glycol-structure and glycan changes of the target protein and it might be useful to findout the biomarker and therapeutic agent.
靶点名称T / Tn Antigen
別名T / Tn Antigen antibody; Tn antigen antibody; Thomsen-Friedenreich Antigen antibody
属性
存放说明For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
注意事项For laboratory research only, not for drug, diagnostic or other use.
生物信息
全名Antibody Duo for T / Tn Antigen (T , Tn)
研究领域Cancer antibody; Cell Biology and Cellular Response antibody; Controls and Markers antibody
参考文献

Shigella flexneri Targets Human Colonic Goblet Cells by O Antigen Binding to Sialyl-Tn and Tn Antigens via Glycan-Glycan Interactions.

ARG62636, ARG53970: ICC/IF / 

Elizabeth Ngoc Hoa Tran et al.
ACS Infect Dis.,  (2020)

publication_link

 

hr_line
New Products
Get in touch with AREX
Name:*
Tel/Phone:*
Company:*
Email:*
Inquiry:
Captcha*
Submitting your email information means that you are willing to receive email information from AREX regarding technology, applications, products, and events. By clicking on the 'unsubscribe' button in the email or by contacting info@arexbio.com You can unsubscribe at any time by sending an email. Regarding your data usage information, please refer to our privacy policy.
© AREX 2024. All Rights Reserved. | 浙ICP备2024113709号-3 Sitemap